Studies related to Glucagon and Fish Oil

Effect Of Omega 3 Fatty Acid On Plasma Lipids, Cholesterol And Lipoprotein Fatty Acid Content In NIDDM Patients

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 28
Sex n/a
Age Range 45-64
Body Types Overweight
Notes for this study:
1.4g EPA and 880mg DHA for 3 months in 28 type II diabetics of undisclosed gender (with placebo given linseed oil, a source of omega-3 as ALA) noted a reduction in triglycerides but no other parameter appeared to be altered.